Horizon Technology Finance(US:HRZN)2026-03-04 15:00Financial Data and Key Metrics Changes - The company generated net investment income (NII) of $0.18 per share for Q4 2025, down from $0.32 per share in Q3 2025 and $0.27 per share in Q4 2024 [23][24] - The net asset value (NAV) per share was $6.98 as of December 31, 2025, compared to $7.12 as of September 30, 2025, and $8.43 as of December 31, 2024 [26] - Total investment income for Q4 2025 was $21 million, down from $24 million in the prior year period [21] Business Line Data and Key Metrics Changes - The portfolio yield on debt investments was over 14% for Q4 2025 and nearly 16% for the full year 2025, maintaining a competitive position within the BDC industry [7] - The company funded nine debt investments totaling $103 million in Q4 2025, with a total investment portfolio of $647 million at year-end [9][25] - The committed backlog increased by $35 million from Q3 2025, reaching $154 million by year-end [12] Market Data and Key Metrics Changes - Approximately $92 billion was invested in VC-backed companies in Q4 2025, indicating a recovery in investment activity [13] - The exit markets remained open but slow, with about $100 billion of exit value primarily driven by tech IPOs [14] - The demand for venture debt capital remains high, positioning the company as a key supplier in the coming year [8] Company Strategy and Development Direction - The impending merger with Monroe Capital is expected to significantly increase equity capital available for investment and enhance economies of scale [5] - The company aims to originate larger venture loans to both private and small-cap public companies, leveraging the merger to grow its portfolio and NII over time [9][17] - The focus on venture debt as a compelling option for companies to access capital with lower dilution is a strategic priority [16] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenges faced in 2025 but expressed optimism about the groundwork laid for long-term success [4] - The company expects to see increased NII over time as it grows its portfolio and capitalizes on high-quality investment opportunities [17] - The management highlighted the importance of navigating the changing environment, particularly in AI and defense technology sectors [16] Other Important Information - The company redeemed its notes due in 2026 and issued new 7% notes due 2028, improving its debt structure [7][19] - The liquidity position as of December 31, 2025, included $189 million in available liquidity, consisting of $143 million in cash and $46 million in funds available to be drawn [20] Q&A Session Summary Question: About the new dividend level decision - The company reviews its distribution level with the board each quarter, considering the current portfolio, run rate, spillover, and growth opportunities to determine a sustainable level [28] Question: Clarification on the percentage at contractual floor - The percentage at contractual floor is indeed 71% [29] Question: Understanding the earnings slide quarter-over-quarter - The lower interest income was primarily driven by reduced prepayment activity and the timing of fundings, which impacted NII [33][35] Question: Opportunities for public company financing - The company sees a combination of refinancing existing debt and providing new capital as significant opportunities in the market [38] Question: Status of non-accrual portfolio companies - The company is actively working on maximizing recoveries for non-accruals, which are at various levels [43] Question: Drivers of realized loss - The realized loss included a small position in Tallac Therapeutics, but specific details on private companies cannot be disclosed [47] Question: Support for the new dividend - The advisor has agreed to waive $4 million of fees for four quarters following the merger to support the dividend [51]